Lotus Pharmaceutical Co (TPE:1795) Other Current Receivables: NT$852 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1795 Lotus Pharmaceutical Co Ltd TPE:1795
76 GF Score
Price NT$188.50
GF Value NT$459.06
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Lotus Pharmaceutical Co Other Current Receivables?

Lotus Pharmaceutical Co TPE:1795 -2.08% 76 Other Current Receivables is NT$852 Mil as of Dec. 2025. GuruFocus rates TPE:1795 with a GF Score™ of 76/100 and a GF Value™ of NT$459.06 (Possible Value Trap). The stock has 4 warning signs investors should review.

Lotus Pharmaceutical Co's Other Current Receivables for the quarter that ended in Dec. 2025 was NT$852 Mil.

Lotus Pharmaceutical Co's quarterly Other Current Receivables declined from Jun. 2025 (NT$168.09 Mil) to Sep. 2025 (NT$138.31 Mil) but then increased from Sep. 2025 (NT$138.31 Mil) to Dec. 2025 (NT$852.25 Mil).

Lotus Pharmaceutical Co's annual Other Current Receivables increased from Dec. 2023 (NT$299.93 Mil) to Dec. 2024 (NT$357.85 Mil) and increased from Dec. 2024 (NT$357.85 Mil) to Dec. 2025 (NT$852.25 Mil).

Lotus Pharmaceutical Co Other Current Receivables Related Terms

Lotus Pharmaceutical Co Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Lotus Pharmaceutical Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Pharmaceutical Co Other Current Receivables Chart

Lotus Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 170.99 480.75 299.93 357.85 852.25

Lotus Pharmaceutical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 357.85 149.20 168.09 138.31 852.25
TPE:1795
76GF Score
Lotus Pharmaceutical Co Ltd TPE:1795
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lotus Pharmaceutical Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of NT$852 Mil mean?
Lotus Pharmaceutical Co (TPE:1795) has a Other Current Receivables of NT$852 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Lotus Pharmaceutical Co and its competitors.
Is Lotus Pharmaceutical Co's Other Current Receivables too high?
Lotus Pharmaceutical Co's current Other Current Receivables is NT$852 Mil. Overall, Lotus Pharmaceutical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lotus Pharmaceutical Co's Other Current Receivables compare to ZTS and UTHR?
Lotus Pharmaceutical Co's Other Current Receivables of NT$852 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Lotus Pharmaceutical Co and its competitors. Lotus Pharmaceutical Co's current Other Current Receivables is NT$852 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Lotus Pharmaceutical Co (TPE:1795) is currently considered Possible Value Trap. The stock's GF Value™ is NT$459.06, compared to a current price of NT$188.50 — trading 58.9% below its estimated fair value. The current Other Current Receivables is NT$852 Mil. Lotus Pharmaceutical Co's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Lotus Pharmaceutical Co (TPE:1795), the current Other Current Receivables is NT$852 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lotus Pharmaceutical Co (TPE:1795) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$188.50 is trading 58.9% below its estimated GF Value™ of NT$459.06. GuruFocus considers Lotus Pharmaceutical Co to be Possible Value Trap.

Key valuation signals for TPE:1795:

  • Other Current Receivables: NT$852 Mil
  • GF Value™: NT$459.06 vs. price of NT$188.50 (58.9% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the TPE:1795 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lotus Pharmaceutical Co Business Description

Address Song Ren Road, No. 277, 17th Floor, Xin Yi District, Taipei, TWN, 11046
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. Along with its subsidiaries, it is engaged in the research and development, manufacturing, and sales of generic and branded pharmaceutical products, as well as consulting services. Its product portfolio comprises biosimilars, generic medicines, branded medicines, and various therapies in its research and development pipeline. The Group offers a differentiated portfolio of pharmaceuticals spanning several therapeutic areas, including oncology and immunology, CNS, women's health, primary care and lifestyle, and nephrology, among others. Geographically, it generates maximum revenue from the United States, and the rest from Taiwan, South Korea, Singapore, and other countries.
76GF Score

Get the complete analysis for TPE:1795

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$188.50
Price
NT$459.06
GF Value